Symptom scores and clinical measures in benign prostatic hyperplasia

doi:10.5410/wjcu.123397

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

(2)

(0)

(18)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Urology

ISSN

2219-2816

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Urol. Sep 16, 2026; 15(2): 123397
Published online Sep 16, 2026. doi: 10.5410/wjcu.123397

Full Size Figure Download Figure

Figure 2 Forest plots. A: Forest plot for the International Prostate Symptom Score (IPSS)-quality of life meta-analysis (k = 5, n = 705). Pooled random-effects r = 0.713 [95% confidence interval (CI): 0.557-0.820; I² = 3.26%]. Studies ordered by publication year; B: Forest plot for the prostate volume-IPSS meta-analysis (k = 12, n = 1446). Pooled random-effects r = 0.457 (95%CI: 0.257-0.619; I² = 38.37%). Studies ordered by publication year; C: Forest plot for the IPSS-post-void residual meta-analysis (k = 11, n = 2663). Pooled random-effects r = 0.363 (95%CI: 0.150-0.543; I² = 51.18%). Studies ordered by publication year.

Citation: Kakooza J, Hakizimana T, Mugenyi M, Akankwasa P, Lewis CR, Mukiibi E, Ssebamala J, Elias SD, Eltahir EA, Okwi N, Mumbere BV. Symptom scores and clinical measures in benign prostatic hyperplasia. World J Clin Urol 2026; 15(2): 123397
URL: https://www.wjgnet.com/2219-2816/full/v15/i2/123397.htm
DOI: https://dx.doi.org/10.5410/wjcu.123397

Kakooza J, Hakizimana T, Mugenyi M, Akankwasa P, Lewis CR, Mukiibi E, Ssebamala J, Elias SD, Eltahir EA, Okwi N, Mumbere BV. Symptom scores and clinical measures in benign prostatic hyperplasia. World J Clin Urol 2026; 15(2): 123397 [DOI: 10.5410/wjcu.123397]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.